ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Benchmarking next-generation large language models in otorhinolaryngology: a prospective, guideline-anchored, blinded evaluation of ChatGPT-5, Gemini-3, Grok-2, Llama-4, and DeepSeek-4 across case scenarios.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeLarge language models (LLMs) are increasingly utilized in medicine; however, their reliability in surgical and diagnostic specialties requiring guideline-anchored reasoning remains underexplored. The study systematically evaluated the performance of five contemporary LLMs in otorhinolaryngology (ENT).
methodsA prospective, two-phase, cross-sectional analysis compared ChatGPT-5 (OpenAI), Gemini-3 (Google), Grok 2 (xAI), Llama 4 (Meta), and DeepSeek-4 (DeepSeek) using 100 standardized ENT clinical scenarios derived from AAO-HNS, ERS, and IFOS guidelines. Each model answered 900 questions (4 open-ended and 5 multiple-choice questions per case), and the process was repeated one month later to assess temporal stability. Two board-certified otorhinolaryngologists, blinded to the study, rated all 9,000 responses for accuracy, comprehensiveness, and adherence to guidelines on a 6-point scale. Statistical analyses included Kruskal–Wallis, Dunn’s post-hoc, Wilcoxon, and ICC reliability testing.
resultsInter-rater reliability was excellent (ICC = 0.91; Cronbach’s α = 0.89). Significant inter-model differences were found across all domains (p < 0.001). ChatGPT-5 achieved the highest composite score (5.58 ± 0.24), outperforming Gemini-3 (5.42 ± 0.28; p < 0.01) and other models within a narrow, clinically credible band (5.05–5.30). Accuracy was higher for multiple-choice than open-ended items (p = 0.027), with ChatGPT-5 showing the smallest format gap. All models demonstrated strong alignment with international ENT guidelines and adhered to clinical safety standards. Temporal stability was greatest in ChatGPT-5 and Gemini-3, with minimal drift between test phases (Δ < 0.1).
conclusionAll evaluated LLMs delivered high factual and guideline-based reasoning in otolaryngology, with ChatGPT-5 exhibiting superior precision, completeness, and longitudinal stability. These findings support the supervised integration of LLMs as adjunctive tools for clinical education and decision support in ENT.
Indexed as
Identifiers
42050126What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.